BeOne joins the Kat6 pack
BG-75202 features among several projects starting first-in-human trials.
Pfizer moves into the VEGF bispecific fast lane
There will soon be three PD-(L)1 x VEGF projects in pivotal lung and colorectal cancer trials.
Nuvation reroutes its glioma plan
The company will no longer initiate a head-to-head trial of safusidenib against Voranigo.
Venture capitalists buy into TROP2
Blackstone follows Abingworth, but why?
Amgen's $1.9bn looks buried
The Fortitude-102 trial, testing a bemarituzumab/Opdivo/chemo triplet, has failed.
One of Adcetris’s twin sons strikes out
Pfizer cans PF-08046045, but keeps PF-08046044 for now.
Gastrointestinal is next for pumitamig
Bristol will advance the newest pivotal trials, in first-line colorectal and gastric cancers.
